Intelligent mobility leader celebrates milestone year with triple-digit expansion, industry recognition, and breakthrough ...

Management kept revenue and EBITDA guidance unchanged, despite Q2 outperformance. Jonsdottir stated, "We have also said like in the past that revenue recognition is lumpy with respect to milestone ...

COPENHAGEN, Denmark —2024 proved to be a successful year for Milestone, breaking new ground through the strategic acquisitions of BriefCam analytics and Arcules cloud, and development of new product ...

GAAP revenue surged to $66.8 million in Q2 2025, driven by recognition of one-time license and milestone payments, exceeding analyst estimates by 3,065.9% (GAAP). GAAP loss per share narrowed to ...

AnaptysBio develops innovative antibody therapies for autoimmune and inflammatory diseases. Its business revolves around discovering and advancing engineered antibodies, with a current pipeline that ...

TORONTO, ON AND NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Nextech3D.ai (CSE:NTAR)(OTCQB:NEXCF)(FSE:1SS), an AI-first technology company specializing in event management, 3D modeling, and ...

Adjusted Total Revenue is a non-GAAP financial measure. Adjusted Total Revenue is total revenue excluding Sanofi Supply Sales, Sanofi Royalties and Sanofi Influenza-COVID-19 Combination and Matrix-M ...

GAAP revenue of $18 thousand for Q2 2025 missed estimates by 97.99% and was sharply below the prior year’s revenue for the quarter ended June 30, 2024, due to the conclusion of a major collaboration.

Cytokinetics specializes in the research and development of therapies for cardiovascular and muscle diseases. Its main drug candidate, aficamten, is a cardiac myosin inhibitor -- a type of drug ...